OBJECTIVE: To assess fitness and outcomes in older women undergoing cytoreductive surgery for advanced ovarian cancer (OC). METHODS: A prospective study of OC patients referred to Geriatrics Clinic for preoperative evaluation. All completed the electronic Rapid Fitness Assessment (eRFA) and were followed by Geriatrics Service during inpatient postoperative course, co-managed by Surgical Service. Outcomes were 30-day Intensive Care Unit (ICU) admission, emergency room (ER) visit, readmission, mortality, adverse surgical events. Descriptive statistics were used. RESULTS: Forty-two women (median age 79, range 74-88), 38 with newly diagnosed advanced OC, 4 with recurrent OC, underwent cytoreductive surgery between 5/2015 and 1/2018. Preoperative age-related impairments per eRFA: high level of distress (71%), functional dependency (59%), limited social activity (59%), depression (57%), slow Time Up and Go (54%), Karnofsky Performance Score (KPS) ≤ 80 (41%), poor social support (43%), polypharmacy (35%), weight loss>10 lbs. (25%), fall history (244%), cognitive impairment (13%). Median number of comorbid conditions = 3. Among 38 newly diagnosed women, 26 (68%) had stage IIIC, 11 (29%) stage IV. Sixteen (42%) underwent primary debulking surgery, 22 (58%) neoadjuvant chemotherapy followed by interval debulking surgery. Median duration of surgery = 245.5 min (range 95-621); median hospital length of stay = 6 days (range 0-22). Optimal debulking rate = 97%, complete gross resection rate = 63%. One patient was admitted to ICU, 26% had 30-day ER visit, 10% were readmitted. Any complication, minor complication, major complication occurred in 58%, 55%, 8%, respectively. Median time from surgery to postoperative chemotherapy = 34.5 days (range 19-66). Median follow-up = 15.7 months (range 3.7-38.0), 12-month survival = 93.3%. There was no 180-day mortality. CONCLUSION: Cytoreductive surgery among older women with advanced OC and frailty can be performed safely in a tertiary care center with preoperative/postoperative geriatric and surgical co-management.
OBJECTIVE: To assess fitness and outcomes in older women undergoing cytoreductive surgery for advanced ovarian cancer (OC). METHODS: A prospective study of OC patients referred to Geriatrics Clinic for preoperative evaluation. All completed the electronic Rapid Fitness Assessment (eRFA) and were followed by Geriatrics Service during inpatient postoperative course, co-managed by Surgical Service. Outcomes were 30-day Intensive Care Unit (ICU) admission, emergency room (ER) visit, readmission, mortality, adverse surgical events. Descriptive statistics were used. RESULTS: Forty-two women (median age 79, range 74-88), 38 with newly diagnosed advanced OC, 4 with recurrent OC, underwent cytoreductive surgery between 5/2015 and 1/2018. Preoperative age-related impairments per eRFA: high level of distress (71%), functional dependency (59%), limited social activity (59%), depression (57%), slow Time Up and Go (54%), Karnofsky Performance Score (KPS) ≤ 80 (41%), poor social support (43%), polypharmacy (35%), weight loss>10 lbs. (25%), fall history (244%), cognitive impairment (13%). Median number of comorbid conditions = 3. Among 38 newly diagnosed women, 26 (68%) had stage IIIC, 11 (29%) stage IV. Sixteen (42%) underwent primary debulking surgery, 22 (58%) neoadjuvant chemotherapy followed by interval debulking surgery. Median duration of surgery = 245.5 min (range 95-621); median hospital length of stay = 6 days (range 0-22). Optimal debulking rate = 97%, complete gross resection rate = 63%. One patient was admitted to ICU, 26% had 30-day ER visit, 10% were readmitted. Any complication, minor complication, major complication occurred in 58%, 55%, 8%, respectively. Median time from surgery to postoperative chemotherapy = 34.5 days (range 19-66). Median follow-up = 15.7 months (range 3.7-38.0), 12-month survival = 93.3%. There was no 180-day mortality. CONCLUSION: Cytoreductive surgery among older women with advanced OC and frailty can be performed safely in a tertiary care center with preoperative/postoperative geriatric and surgical co-management.
Authors: Vivian E von Gruenigen; Helen Q Huang; Jan H Beumer; Heather A Lankes; William Tew; Thomas Herzog; Arti Hurria; Robert S Mannel; Tina Rizack; Lisa M Landrum; Peter G Rose; Ritu Salani; William H Bradley; Thomas J Rutherford; Robert V Higgins; Angeles Alvarez Secord; Gini Fleming Journal: Gynecol Oncol Date: 2017-01-13 Impact factor: 5.482
Authors: G Freyer; J-F Geay; S Touzet; J Provencal; B Weber; J-P Jacquin; G Ganem; N Tubiana-Mathieu; O Gisserot; E Pujade-Lauraine Journal: Ann Oncol Date: 2005-08-10 Impact factor: 32.976
Authors: Ignace Vergote; Claes G Tropé; Frédéric Amant; Gunnar B Kristensen; Tom Ehlen; Nick Johnson; René H M Verheijen; Maria E L van der Burg; Angel J Lacave; Pierluigi Benedetti Panici; Gemma G Kenter; Antonio Casado; Cesar Mendiola; Corneel Coens; Leen Verleye; Gavin C E Stuart; Sergio Pecorelli; Nick S Reed Journal: N Engl J Med Date: 2010-09-02 Impact factor: 91.245
Authors: Dennis S Chi; Fernanda Musa; Fanny Dao; Oliver Zivanovic; Yukio Sonoda; Mario M Leitao; Douglas A Levine; Ginger J Gardner; Nadeem R Abu-Rustum; Richard R Barakat Journal: Gynecol Oncol Date: 2011-09-13 Impact factor: 5.482
Authors: Amina Ahmed; Wei Deng; William Tew; David Bender; Robert S Mannel; Ramey D Littell; Albert S DeNittis; Mitchell Edelson; Mark Morgan; Jay Carlson; Christopher J Darus; Aimee C Fleury; Susan Modesitt; Alexander Olawaiye; Anthony Evans; Gini F Fleming Journal: Gynecol Oncol Date: 2018-05-26 Impact factor: 5.482
Authors: Jean-Pierre Droz; Matti Aapro; Lodovico Balducci; Helen Boyle; Thomas Van den Broeck; Paul Cathcart; Louise Dickinson; Eleni Efstathiou; Mark Emberton; John M Fitzpatrick; Axel Heidenreich; Simon Hughes; Steven Joniau; Michael Kattan; Nicolas Mottet; Stéphane Oudard; Heather Payne; Fred Saad; Toru Sugihara Journal: Lancet Oncol Date: 2014-08 Impact factor: 41.316
Authors: Larissa A Meyer; Weiguo He; Charlotte C Sun; Hui Zhao; Alexi A Wright; Rudy S Suidan; Joseph Dottino; J Alejandro Rauh-Hain; Karen H Lu; Sharon H Giordano Journal: Gynecol Oncol Date: 2018-06-29 Impact factor: 5.482
Authors: Gabriel Raab; Daniel Restifo; Sean M McBride; Richard J Wong; Nancy Y Lee; Armin Shahrokni; Kaveh Zakeri Journal: J Geriatr Oncol Date: 2021-10-28 Impact factor: 3.599
Authors: Olga T Filippova; Amy L Tin; Joanne Alonso; Andrew J Vickers; William P Tew; Ginger J Gardner; Yukio Sonoda; Kara Long Roche; Oliver Zivanovic; Dennis S Chi; Armin Shahrokni Journal: Gynecol Oncol Date: 2021-03-25 Impact factor: 5.304
Authors: Armin Shahrokni; Amy L Tin; Saman Sarraf; Koshy Alexander; Steve Sun; Soo Jung Kim; Sincere McMillan; Heidi Yulico; Farnia Amirnia; Robert J Downey; Andrew J Vickers; Beatriz Korc-Grodzicki Journal: JAMA Netw Open Date: 2020-08-03
Authors: Gregory T Chesnut; Amy L Tin; Daniel D Sjoberg; Brian Jang; Nicole Benfante; Saman Sarraf; Harry Herr; S Machele Donat; Guido Dalbagni; Bernard Bochner; Armin Shahrokni; Alvin C Goh Journal: J Urol Date: 2020-09-08 Impact factor: 7.450